Abstract
Recent studies have shown elevated homocysteine levels in patients with eating disorders. In a prospective, longitudinal study, we investigated differences of homocysteine plasma levels in patients with anorexia nervosa (N = 12) and bulimia nervosa (N = 17) compared to healthy controls (N = 20) and alteration of homocysteine levels in patients during specific in-patient treatment. We found significantly elevated homocysteine levels in both patient groups (anorexia nervosa and bulimia nervosa) and a non-significant decrease of homocysteine during the 12-week treatment period. Furthermore, we found a significant association between low homocysteine levels and cognitive deficits, pointing toward a beneficial effect of elevated homocysteine levels on cognition in this patient group. We suppose that during effective treatment with significant increase of the body mass index, the observed hyperhomocysteinemia in patients with eating disorders is partially reversible. These findings add further evidence to the hypothesis that homocysteine might be involved in the pathophysiology of anorexia and bulimia nervosa.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bäumler G (1985) Colour word interference test. Hogrefe, Göttingen
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM (2003) Folate, vitamin B12, homocysteine, and the MTHFR 677C→T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 60:618–626
Bleich S, Degner D, Javaheripour K, Kurth C, Kornhuber J (2000) Homocysteine and alcoholism. J Neural Transm (Suppl):187–196
Bleich S, Romer K, Wiltfang J, Kornhuber J (2003) Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 18:S33–S40
Bleich S, Carl M, Bayerlein K, Reulbach U, Biermann T, Hillemacher T, Bonsch D, Kornhuber J (2005) Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS). Alcohol Clin Exp Res 29:334–336. doi:00000374-200503000-00006[pii]
Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH (2000) Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69:228–232
Brickenkamp R (2002) d2 Test of attention, 9th edn. Hogrefe, Göttingen
Christie LA, Riedel G, Algaidi SA, Whalley LJ, Platt B (2005) Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine. Neurosci Lett 373:119–124. doi:S0304-3940(04)01237-6[pii]10.1016/j.neulet.2004.09.072
Clarke R, Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26:341–348
de Bree A, Verschuren WM, Blom HJ, Kromhout D (2001) Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 154:150–154
Folstein M, Liu T, Peter I, Buel J, Arsenault L, Scott T, Qiu WW (2007) The homocysteine hypothesis of depression. Am J Psychiatry 164:861–867
Frieling H, Römer K, Röschke B, Bönsch D, Wilhelm J, Fiszer R, de Zwaan M, Jacoby GE, Kornhuber J, Bleich S (2005a) Homocysteine plasma levels are elevated in females with anorexia nervosa. J Neural Transm 112:979–985
Frieling H, Röschke B, Kornhuber J, Wilhelm J, Römer KD, Gruß B, Bönsch D, Hillemacher T, Md Zwaan, Jacoby GE, Bleich S (2005b) Cognitive impairment and its association with homocysteine plasma levels in females with eating disorders—findings from the HEaD-study. J Neural Transm V112:1591–1598
Frieling H, Romer KD, Beyer S, Hillemacher T, Wilhelm J, Jacoby GE, de Zwaan M, Kornhuber J, Bleich S (2008) Depressive symptoms may explain elevated plasma levels of homocysteine in females with eating disorders. J Psychiatr Res 42:83–86. doi:S0022-3956(06)00212-3[pii]10.1016/j.jpsychires.2006.10.007
Kang SS, Wong PW, Norusis M (1987) Homocysteinemia due to folate deficiency. Metabolism 36:458–462
Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20:6920–6926. doi:20/18/6920[pii]
Lehfeld H, Erzigkeit H (1997) The SKT—a short cognitive performance test for assessing deficits of memory and attention. Int Psychogeriatr 9(Suppl 1):115–121
Lehfeld H, Rudinger G, Rietz C, Heinrich C, Wied V, Fornazzari L, Pittas J, Hindmarch I, Erzigkeit H (1997) Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention. Int Psychogeriatr 9:139–153
Lehrl S (2005) MWT-B: Mehrfach Wortschatz Intelligenztest, 5th edn. Hogrefe, Göttingen
Levine J, Gur E, Loewenthal R, Vishne T, Dwolatzky T, IMv Beynum, Sela B-A, Vered I, Yosef G, Stein D (2007) Plasma homocysteine levels in female patients with eating disorders. Int J Eat Disord 40:277–284
Ling BL, Dewaele C, Baeyens WR (1990) Application of micro-scale liquid chromatography with fluorescence detection to the determination of thiols. J Chromatogr 514:189–198
Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc Natl Acad Sci USA 94:5923–5928
Loscalzo J (2002) Homocysteine and dementias. N Engl J Med 346:466–468. doi:10.1056/NEJM200202143460702346/7/466[pii]
Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Moyano D, Vilaseca MA, Artuch R, Valls C, Lambruschini N (1998) Plasma total-homocysteine in anorexia nervosa. Eur J Clin Nutr 52:172–175
Ohrmann P, Kersting A, Suslow T, Lalee-Mentzel J, Donges US, Fiebich M, Arolt V, Heindel W, Pfleiderer B (2004) Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 15:549–553. doi:00001756-200403010-00033[pii]
Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM (2002) Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 59:1375–1380
Schmidtke A, Fleckenstein P, Moises W, Beckmann H (1988) Studies of the reliability and validity of the German version of the Montgomery–Asberg Depression Rating Scale (MADRS). Schweiz Arch Neurol Psychiatr 139:51–65
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483
Ueland PM, Nygard O, Vollset SE, Refsum H (2001) The Hordaland Homocysteine Studies. Lipids 36(Suppl):S33–S39
Van Binsbergen CJ, Odink J, Van den Berg H, Koppeschaar H, Coelingh Bennink HJ (1988) Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc. Eur J Clin Nutr 42:929–937
Wilhelm J, Bayerlein K, Hillemacher T, Reulbach U, Frieling H, Kromolan B, Degner D, Kornhuber J, Bleich S (2006) Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism. J Neural Transm 113:357–363
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilhelm, J., Müller, E., de Zwaan, M. et al. Elevation of homocysteine levels is only partially reversed after therapy in females with eating disorders. J Neural Transm 117, 521–527 (2010). https://doi.org/10.1007/s00702-010-0379-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-010-0379-6